NASDAQ:SLXN
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN
Silexion Therapeutics Corp shares soared on Nasdaq Wednesday, ending the session up 96.95% at $0.5298. Shares had finished at $0.269 the day before. After the close, the stock dropped 9.5% in after-hours action. Volume…
Company hubNASDAQ:SLXN
SLXN (SLXN) Stock News & Analysis
Follow the latest SLXN (SLXN) company news, earnings coverage and investor analysis from TechStock².
Save this hub to your TS2 Signalbook account.
- Latest update
- Articles in this hub
- 1
- Last 30 days
- 0
What investors are watching
- Earnings, guidance and financial performance
- Valuation, trading activity and market sentiment
- Strategy, catalysts and company-specific risks
All coverage